XML 61 R50.htm IDEA: XBRL DOCUMENT v3.24.3
STOCK OPTIONS AND WARRANTS (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Feb. 12, 2024
Feb. 09, 2024
Oct. 31, 2017
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 19, 2024
Jul. 11, 2024
May 29, 2024
Dec. 31, 2023
Jun. 06, 2023
Jan. 31, 2022
Jul. 31, 2021
Intrinsic value       $ 0   $ 0                
intrinsic value, exercisable       0   0                
Stock-based compensation expense       27,954 $ 343,951 $ 100,168 $ 954,317              
Minimum number of common stock shares issuable                 2,000,000          
Maximum number of common stock shares issuable                 2,500,000          
Option granted under the 2024 Plan description           Any option granted under the 2024 Plan must provide for an exercise price of not less than 100% of the fair market value of the underlying shares on the date of grant and not less than $4.00 per share, but the exercise price of any ISO granted to an eligible employee owning more than 10% of our outstanding common stock must not be less than 110% of fair market value on the date of the grant. The plans further provide that with respect to ISOs the aggregate fair market value of the common stock underlying the options which are exercisable by any option holder during any calendar year cannot exceed $100,000                
Units, issued                         228,530 180,000
Non-vested stock options 2024       26,053   $ 26,053                
Non-vested stock options periods 2025       89,018   89,018                
Non-vested stock options periods 2026       14,683   14,683                
Non-vested stock options periods 2027       1,223   1,223                
Total unrecognized compensation cost           131,273                
Non-vested stock options periods thereafter       $ 296   $ 296                
Purchase Warrants   108,912                        
Debt cancelled $ 302,175 $ 289,882                        
weighted average remaining life           2 years 8 months 12 days                
Common shares issued 104,274     12,184,109   12,184,109   720,000   150,000 1,433,903 481,000    
Stocks Option [Member] | 2017 Equity Incentive Plan [Member]                            
Option granted, description     Any option granted under the 2021 Plan must provide for an exercise price of not less than 100% of the fair market value of the underlying shares on the date of grant and not less than $4.00 per share, but the exercise price of any ISO granted to an eligible employee owning more than 10% of our outstanding common stock must not be less than 110% of fair market value on the date of the grant. The plans further provide that with respect to ISOs the aggregate fair market value of the common stock underlying the options which are exercisable by any option holder during any calendar year cannot exceed $100,000                      
Calvary [Member]                            
Purchase Warrants   104,274